NORTHSTRIVE FUND II LP → Bluejay Diagnostics, Inc. BJDX

Stake: — Shares: 0 CUSIP: 095633608 Class: Common Stock, $0.0001 par value per share

Composite Decision Signal · AVOID (DILUTION / EXIT TRAP) Conviction Score: 18/100

Disqualifiers: ACTIVIST_STAKE_EXIT: SCHEDULE 13D/A reduces ownership below 5% threshold (0.00%)

Active Schedule 13D filer baseline

Item 4 — Purpose of Transaction

Since the filing of the Reporting Persons' Schedule 13D with the SEC on March 11, 2026, the Reporting Persons have disposed of all shares of common stock of the Issuer. As of June 2, 2026, the Reporting Persons no longer beneficially own any shares of the Issuer's Common Stock.

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.00

144,402 shares short · +0.5% vs prior

Post-Filing Returns · since 2026-06-02 on BJDX

+1 day

+3.9%

+5 days

+20.5%

+30 days

-73.7%

+60 days

—

+90 days

—

+180 days

—

Anchor price 4.34 on closest trading day on/after 2026-06-02. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Bluejay Diagnostics, Inc.

Filed	Form	Filer	Stake	Shares
2026-06-05	SCHEDULE 13G	INTRACOASTAL CAPITAL, LLC	—	—	view →
2026-06-02	SCHEDULE 13D/A	Braeden Lichti	—	0	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →